Stem cell pioneer NeuroScientific Biopharmaceuticals is transferring its patented StemSmart technology to one of Australia’s ...

NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment. Melbourne-based exec Nathan Smith is bringing ...

The crosstalk between stromal cells, immune cells, and cancer cells enhances proliferative and drug-resistant phenotypes of cancer cells through the exchange of cytokines and activation of multiple ...